Trials / Completed
CompletedNCT00653315
Bioavailability Study of Tramadol/APAP Tablets Under Fasting Conditions
To Compare the Relative Bioavailability of the Kali's Tramadol APAP Tablets With Ortho-McNeil's Ultracet Tablets Under Fasting Conditions.
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 28 (actual)
- Sponsor
- Par Pharmaceutical, Inc. · Industry
- Sex
- All
- Age
- 18 Years – 45 Years
- Healthy volunteers
- Accepted
Summary
To compare the relative bioavailability of Kali and Ortho-McNeil's
Detailed description
To compare the relative bioavailability of Kali's Tramadol/APAP 37.5mg/325mg with Ortho-McNeil's Ultracet tablets 37.5mg/325mg
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Tramadol APAP | Tablets, 37.5mg/325mg, single dose |
| DRUG | Ultracet | Tablets, 37.5mg/325mg |
Timeline
- Start date
- 2002-05-01
- Primary completion
- 2002-08-01
- Completion
- 2002-08-01
- First posted
- 2008-04-04
- Last updated
- 2008-04-11
Source: ClinicalTrials.gov record NCT00653315. Inclusion in this directory is not an endorsement.